Tag: liquid embolic
Landmark MMA embolisation trials published in New England Journal of Medicine
Detailed results from three randomised controlled trials (RCTs) evaluating middle meningeal artery (MMA) embolisation in the treatment of chronic subdural haematoma (cSDH) have been...
Novel liquid embolic agent meets primary feasibility and safety endpoints in...
Arsenal Medical has announced that NeoCast—a first-of-its-kind, shear-responsive liquid embolic material designed for deep distal penetration—met its primary feasibility and safety endpoints in the...
Recent breakthroughs in cSDH intervention may lead to “HERMES-style collaborative”
Following their initial presentation earlier this year, two randomised controlled trials (RCTs) indicating positive outcomes with middle meningeal artery (MMA) embolisation in chronic subdural...
“Terrible complication” highlights subtle challenges of treating dAVFs via embolisation
“I think complication discussion is one of the most important parts of our job,” said Edoardo Boccardi (Niguarda Hospital, Milan, Italy), prefacing his presentation...
SNIS acknowledges “major shift” in chronic SDH treatment following new trial...
In an official statement, the Society of Neurolnterventional Surgery (SNIS) has acknowledged middle meningeal artery (MMA) embolisation as a beneficial adjunctive treatment for chronic...
STEM study finds improved outcomes with MMA embolisation over standard care...
Recently presented results from the STEM randomised controlled trial (RCT) have demonstrated improved outcomes with middle meningeal artery (MMA) embolisation plus standard management—as compared...
Arsenal Medical announces treatment of first patient with NeoCast embolic biomaterial
Arsenal Medical has today announced enrolment of the first patient treated with the company’s investigational NeoCast embolic biomaterial for neurovascular conditions.
The patient was successfully...
Squid liquid embolic agent deemed safe and effective for high-grade DAVFs
The Squid liquid embolic agent (Balt) has been deemed safe and effective in treating high-grade dural arteriovenous fistulas (DAVFs), and serves to expand the...
Balt announces receiving CE mark for Magic Glue, a next generation...
Balt International has announced receiving the CE mark for Magic Glue, its next generation of cyanoacrylate liquid embolic agent. Magic Glue is indicated for...
